Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 152

    2.

    Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations.

    Weng J, Macfarlane WM, Lehto M, Gu HF, Shepherd LM, Ivarsson SA, Wibell L, Smith T, Groop LC.

    Diabetologia. 2001 Feb;44(2):249-58.PMID: 11270685 [PubMed - indexed for MEDLINE]Related articles

    3.

    Hepatocyte nuclear factor-6: associations between genetic variability and type II diabetes and between genetic variability and estimates of insulin secretion.

    Møller AM, Ek J, Durviaux SM, Urhammer SA, Clausen JO, Eiberg H, Hansen T, Rousseau GG, Lemaigre FP, Pedersen O.

    Diabetologia. 1999 Aug;42(8):1011-6.PMID: 10491763 [PubMed - indexed for MEDLINE]Related articles

    4.

    Meta-analysis of the IPF1 D76N polymorphism in a worldwide type 2 diabetes population.

    Gragnoli C, Cronsell J.

    Minerva Med. 2007 Jun;98(3):163-6.PMID: 17592437 [PubMed - indexed for MEDLINE]Related articles

    5.

    Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in caucasians.

    Hansen L, Urioste S, Petersen HV, Jensen JN, Eiberg H, Barbetti F, Serup P, Hansen T, Pedersen O.

    J Clin Endocrinol Metab. 2000 Mar;85(3):1323-6.PMID: 10720084 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.
    7.

    Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.

    Hani EH, Stoffers DA, Chèvre JC, Durand E, Stanojevic V, Dina C, Habener JF, Froguel P.

    J Clin Invest. 1999 Nov;104(9):R41-8.PMID: 10545531 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes.

    Gragnoli C, Stanojevic V, Gorini A, Von Preussenthal GM, Thomas MK, Habener JF.

    Metabolism. 2005 Aug;54(8):983-8.PMID: 16092045 [PubMed - indexed for MEDLINE]Related articles

    9.

    Mutations in the insulin promoter factor-1 gene in late-onset type 2 diabetes mellitus.

    Reis AF, Ye WZ, Dubois-Laforgue D, Bellanné-Chantelot C, Timsit J, Velho G.

    Eur J Endocrinol. 2000 Oct;143(4):511-3.PMID: 11022198 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Insulin Promoter Factor 1 variation is associated with type 2 diabetes in African Americans.

    Karim MA, Wang X, Hale TC, Elbein SC.

    BMC Med Genet. 2005 Oct 17;6:37.PMID: 16229747 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes.

    Macfarlane WM, Frayling TM, Ellard S, Evans JC, Allen LI, Bulman MP, Ayres S, Shepherd M, Clark P, Millward A, Demaine A, Wilkin T, Docherty K, Hattersley AT.

    J Clin Invest. 1999 Nov;104(9):R33-9.PMID: 10545530 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Molecular scanning for mutations in the insulin receptor substrate-1 (IRS-1) gene in Mexican Americans with Type 2 diabetes mellitus.

    Celi FS, Negri C, Tanner K, Raben N, De Pablo F, Rovira A, Pallardo LF, Martin-Vaquero P, Stern MP, Mitchell BD, Shuldiner AR.

    Diabetes Metab Res Rev. 2000 Sep-Oct;16(5):370-7.PMID: 11025561 [PubMed - indexed for MEDLINE]Related articles

    13.

    Missense mutations in the human insulin promoter factor-1 gene are not a common cause of type 2 diabetes mellitus in Taiwan.

    Shiau MY, Huang CN, Liao JH, Chang YH.

    J Endocrinol Invest. 2004 Dec;27(11):1076-80.PMID: 15754742 [PubMed - indexed for MEDLINE]Related articles

    14.

    A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study.

    Staiger H, Stancáková A, Zilinskaite J, Vänttinen M, Hansen T, Marini MA, Hammarstedt A, Jansson PA, Sesti G, Smith U, Pedersen O, Laakso M, Stefan N, Fritsche A, Häring HU.

    Diabetes. 2008 Feb;57(2):514-7. Epub 2007 Nov 26.PMID: 18039816 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Role of a proline insertion in the insulin promoter factor 1 (IPF1) gene in African Americans with type 2 diabetes.

    Elbein SC, Wang X, Karim MA, Freedman BI, Bowden DW, Shuldiner AR, Brancati FL, Kao WH.

    Diabetes. 2006 Oct;55(10):2909-14.PMID: 17003361 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies.

    Grarup N, Rose CS, Andersson EA, Andersen G, Nielsen AL, Albrechtsen A, Clausen JO, Rasmussen SS, Jørgensen T, Sandbaek A, Lauritzen T, Schmitz O, Hansen T, Pedersen O.

    Diabetes. 2007 Dec;56(12):3105-11. Epub 2007 Sep 7.PMID: 17827400 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    IPF-1 gene variation and the development of type 2 diabetes.

    Silver K, Shetty A.

    Mol Genet Metab. 2002 Mar;75(3):287-9.PMID: 11914043 [PubMed - indexed for MEDLINE]Related articles

    19.

    Mutations in MODY genes are not common cause of early-onset type 2 diabetes in Mexican families.

    Domínguez-López A, Miliar-García A, Segura-Kato YX, Riba L, Esparza-López R, Ramírez-Jiménez S, Rodríguez-Torres M, Canizales-Quinteros S, Cabrera-Vásquez S, Fragoso-Ontiveros V, Aguilar-Salinas CA, Altamirano-Bustamante N, Calzada-León R, Robles-Valdés C, Bravo-Ríos LE, Tusié-Luna MT.

    JOP. 2005 May 10;6(3):238-45.PMID: 15883474 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [Association of polymorphism in neurogenic differentiation factor 1 gene with type 2 diabetes]

    Ye L, Xu Y, Zhu Y, Fan Y, Deng H, Zhang J.

    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Dec;19(6):484-7. Chinese. PMID: 12476420 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data